A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects
Clinical trial NCT01649999 · COMPLETED
Trial details
- NCT number
- NCT01649999
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-03-01
- Primary completion
- 2013-07-20
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.